Continuing Education

Objective: Current guidelines recommend use of combination therapy with angiotensin receptor blocker and neprilysin inhibitor (ARNI) (i.e., Entresto®) in patients

Introduction: Despite the importance of physical activity (PA) for cardiovascular health, there is a scarcity of data on objectively measured

Background: Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) was a pragmatic, cluster randomized trial assessing the clinical

Background: Clinical trials have demonstrated that transcatheter mitral valve repair (TMVr) with MitraClip within carefully selected enrolling institutions improves the

Background: In chronic illness caregiving, greater family caregiver exposure to patient symptoms is predictive of greater caregiver psychological and physiological

Background: Sacubitril/valsartan (Entresto®) reduces mortality and heart failure (HF) admissions in NYHA Class II/III HF with reduced ejection fraction (HFrEF).

Introduction: Early bystander initiated cardiopulmonary resuscitation (BCPR) is a key link in the cardiac arrest chain of survival. Prior work

Background: For patients presenting with ST segment elevation myocardial infarction (STEMI), shorter door-to-balloon (D2B) times are associated with lower mortality,

Background: Cardiovascular disease (CVD) remains the number one cause of death amongst women. There has been much effort put forth

Background: Recurrent Myocardial Infarction (MI) after an index MI is a cause for considerable morbidity and mortality. However, the underlying